Clonazepam Orally Disintegrating Tablets, USP (C-IV) Recalled by Endo Due to Potential Mislabeling of Product Carton
Oliver
November 22, 2024
ROCHESTER, MI – As many as 16 lots of Clonazepam Orally Disintegrating Tablets, USP (C-IV) have been added to a voluntary recall by Endo USA, Inc., because the product cartons may be labeled with the incorrect strength, according to the FDA. Indicated to be taken alone or “as an adjunct
